Cannes is NOT the answer anymore...

Sellers held back their best packages from Berlin in February. That isn't speculation. Buyers complained about it openly on the floor at EFM. Screen International quoted Kim Foss of Camera Film, one of the more serious arthouse distributors in Europe: "For the first time in ages, maybe ever, we did not acquire a single film in Berlin."

The reasoning is straightforward. Cannes is where the largest 2026 deals are expected to clear, because Sundance and Berlin have already shown the buyers aren't there for anything below the very top of the slate. 8 weeks out from the Marché, the data going into Cannes 2026 is the worst it's been heading into any Marché in recent memory.

Sundance 2026:

90+ films and episodic series premiered in Park City. About 12 arrived with distribution attached. Roughly 80 entered the festival looking for a buyer.

The top sale was Olivia Wilde's "The Invite," which A24 took for $12 million after Wilde turned down a higher Netflix offer because she wanted theatrical. Seth Rogen, Edward Norton, Penélope Cruz attached. Bidding war confirmed by Deadline at over $10 million before the close.

The Grand Jury Prize and Audience Award winner was "Josephine," a Channing Tatum and Gemma Chan drama directed by Beth de Araújo. It went to Sumerian Pictures, a relative newcomer to the distribution space. Established specialty buyers passed. Last year's Audience winner at Sundance, "A Real Pain," went to Searchlight. The drop in buyer tier for the same prize position is direct.

The most recent Sundance 2026 acquisition arrived on April 23. Almost 3 months after the festival closed. That isn't a market.

EFM 2026:

Attendance was up 5%. More than 12,500 professionals showed up across the week. 606 films screened. 1,794 registered buyers.

The deals did NOT match the foot traffic.

The largest reported transaction at Berlin was Sony's worldwide acquisition of the Brie Larson genre package "Skeletons" for $25 million. After that, volume thinned out fast.

FilmTake's wrap of EFM 2026 ran under the title "Attendance Up, Deals Down, and the Industry's Slow-Motion Correction." Their conclusion: "Deals are not disappearing — they are extending across longer timelines and broader market pathways."

What that means in practice: the deals that close now take 6 to 12 months and require 4 to 8 territories worth of co-financing to come together for the buyer. The festival is no longer a closing venue. It's a starting line for a process that may or may not produce a deal a year later.

Cannes 2025 as the Precedent:

13 of the 22 films in the official Competition slate at Cannes 2025 walked out with a stateside distribution home by the end of the festival. 9 did not.

That's the Competition. The most prestigious 22 films at the most prestigious festival on earth, curated by selection committees specifically for global commercial and critical attention. Featuring Lynne Ramsay, the Dardennes, Joachim Trier, Jafar Panahi, Wes Anderson, Richard Linklater, Scarlett Johansson directing.

41% of that slate didn't sell domestically before the closing ceremony.

Tom Malloy, returning from his 12th Cannes Marché, came home and wrote that "if your movie falls in that $1.5 million to $5 million range, you're in the danger zone." His attendance estimate for Cannes 2025: about two-thirds of the usual industry showed up.

The Marché Reality:

The Cannes Film Market presents around 4,000 films and projects each year to roughly 12,500 industry professionals. The vast majority of those 4,000 leave with no theatrical deal in any major territory. The vast majority of the rest leave with a streaming or AVOD deal that pays a fraction of what was projected when the film was greenlit.

The films that close meaningful theatrical pickups at Cannes share specific traits. A name actor in the lead role with global recognition. A pre-existing relationship between the seller and the buyer. A finished film with strong critical reception out of Competition or a major sidebar. Or a package with named talent attached and credible producers.

Films priced between $700K and $5M almost never have any of those traits. They're built by 1st or 2nd-time directors with limited cast names, sold by sales agents the buyers don't have a working history with, and shopped against thousands of other films in the same tier.

Bleecker Street's Kent Sanderson said the slowness in domestic acquisitions at Cannes 2025 was driven in part by specialty distributors arriving with "full slates" because they'd been investing in production rather than acquisition. That hasn't changed for 2026. A24 produced "The Invite" before acquiring it. Neon's pattern at Sundance 2026 with "Leviticus" was a worldwide rights buy out of WME Independent, not a competitive acquisition. The major specialty buyers are increasingly not buying. They're producing. The acquisition slot is closing on the outside.

What This Looks Like at $700K to $5M:

The list of US distributors who took theatrical risk on a $750K to $5M film from an unknown director in 2025 and recouped meaningful returns for outside investors:

You will not find one.

A24 and Neon's wins in this tier produced their own films. Bleecker Street's slate is increasingly pre-bought packages. IFC and Roadside took genre and arthouse pickups at minimum guarantees that did not return investors at the budget tier we're discussing. Black Bear's "Christy" did $2 million worldwide on Sydney Sweeney's name attached.

The verified theatrical profit story at $750K to $5M from 2025 to early 2026 is empty. Zero filmmakers I can name went to a top-tier specialty distributor with a film in that budget range and produced a return that recouped equity plus a meaningful upside for outside investors.

The micro-budget genre tier under $1M has stories BUT it is a different conversation. The audience build there works on direct-to-consumer paths that the mid-tier indie has never bothered to develop.

The mid-tier indie has been functionally delisted from the buyer's appetite.

The research behind WHY this persists:

George Akerlof's 1970 paper "The Market for Lemons" showed what happens when buyers cannot reliably distinguish quality from junk. Buyers price every product at the average expected quality. Sellers of high-quality goods pull out, because the average price doesn't reward them. The market drifts toward the lowest tier of available product. Akerlof won the Nobel for this work in 2001 because the dynamic shows up everywhere from used cars to insurance to financial securities.

The independent film acquisition market at $700K to $5M is an asymmetric information market. Buyers cannot tell from a finished film whether the audience will show up. Their downstream signals (Pay-1, AVOD, theatrical) are now disrupted enough that they cannot price for it reliably. So they price every film in this tier at the floor, when they price at all. Sellers of genuinely strong films at this budget tier pull out, find another path, or take a deal that doesn't recoup investors. The pool continues to thin.

Robert Frank and Philip Cook's 1995 work "The Winner-Take-All Society" describes markets where rewards concentrate at the top because consumers and buyers cannot meaningfully differentiate the 50th percentile from the 95th. So they default to the obvious top. Festival acquisitions have always been a winner-take-all market. The current tightening is making that pattern more extreme. Sumerian buying the Sundance Audience Award winner is the system telling you what's happening at every tier below the absolute apex.

What the ‘Old Way’ was:

A producer raises $2M to $4M from a mix of equity, soft money, and rebates. The director is a 1st or 2nd feature. A few recognizable names take supporting roles. Production happens. Picture is locked. Sales agent attaches. The film premieres at Sundance, Berlin, SXSW, Tribeca, or Toronto. A US distributor takes the film for a minimum guarantee of $250K to $1M. International rights sell across 15 to 30 territories at total advances of $400K to $2M. Streaming windows generate downstream revenue. Investors recoup over a 3 to 7 year window.

That sequence still exists in textbooks. It does not exist in the data. Minimum guarantees thinned out years ago. International advances dropped. Streaming windows compressed and went disrupted. The festival pickup rate at the unknown-director-mid-budget tier moved toward zero.

The producers and sales agents who built careers on that sequence are still selling it to filmmakers, because that's the product they know how to sell. The investors who funded films in 2018 to 2022 on that sequence are not coming back, because they did not recoup. The new investors are getting pitched the same sequence by the same people, and walking away when they look at recent comparables.

The solution IS NOT to tune the ‘Old Way’:

Cannes 2026 is not going to fix the $700K to $5M tier. The buyers won't be there for it. The packages that close will be Sony genre with Brie Larson. The trickle pickups will go to teams the established buyers have worked with for a decade.

The filmmakers in the dead zone need to abandon the festival-pickup path entirely as the central business case.

What replaces it.

Audience-first development:

The audience is built before the script is locked. Newsletter, YouTube channel, niche community presence, podcast appearances in the genre or subject matter the film addresses. The filmmaker arrives at production with 5,000 to 50,000 verifiable interested viewers, not zero.

Genre under $1M:

Horror, thriller, action-comedy, faith-based, niche cultural, romance for underserved demographics. Where the audience exists in identifiable communities. Where AVOD and direct distribution actually pay. Where production cost matches the ceiling of what those revenue streams currently return.

Direct distribution as the primary path, not the fallback:

The filmmaker builds the distribution before the film exists. Email list, paid platform partnerships, niche theatrical bookings through community presales, regional rollout in markets where the audience lives. The festival route becomes optional marketing, not the central business case.

Investor returns sized to the actual revenue ceiling, not the 2018 ceiling:

A $600K horror film with an existing audience, a documented direct-distribution path, and a 3-to-1 revenue ceiling closes investor money. A $3M drama with no audience, no distribution attached, and a hope that A24 will pick it up in May 2027 does not.

The Cannes Marché will continue every year. The selection committees will continue to program films into Competition. The deals will continue to close at the absolute top of the slate. The 4,000 films at the Marché will continue to leave without a meaningful US theatrical deal.

The filmmakers who keep operating as if Cannes is a viable distribution path for their $2M debut are repeating an old sequence that no longer connects to the market they're walking into. The data from Sundance 2026, EFM 2026, and Cannes 2025 says so directly. The data from Cannes 2026 in May will say it again.

The Marché still has uses as a network event, a co-production conversation, and an international packaging discussion for filmmakers with proven audience traction at home. The festival as a sales mechanism for unknown mid-tier films is over. Treat it that way and proceed accordingly.

Urgency is bullshit. Stop running the old sequence and build for what the data actually shows.